Elicera Therapeutics
is a Private company. Jamal El-Mosleh is the CEO of Elicera Therapeutics. Elicera Therapeutics has raised a total of $3.2M in funding. Elicera Therapeutics has 1 followers on Owler. Elicera Therapeutics has an estimated revenue of <$1M and an estimate of less <10 employees.Elicera Therapeutics
is a Private company. Jamal El-Mosleh is the CEO of Elicera Therapeutics. Elicera Therapeutics has raised a total of $3.2M in funding. Elicera Therapeutics has 1 followers on Owler. Elicera Therapeutics has an estimated revenue of <$1M and an estimate of less <10 employees.
News
Aug 11, 2026
Cision
Press Release: Elicera Therapeutics : Elicera Therapeutics: Last patient treated in the Phase I part of the CARMA study - tumor responses in 10 of 11 patients evaluated to date
Jul 27, 2026
EIN Presswire
Press Release: Elicera Therapeutics : As GetFeedback Direct closes December 31, Simplesat urges customers to protect their data first
Jul 24, 2026
Marketscreener
Elicera Therapeutics: Elicera Therapeutics consolidates its management in Uppsala - CEO transition begins and recruitment of new CEO has started
Jun 19, 2026
Cision
Press Release: Elicera Therapeutics : Elicera Therapeutics Receives Positive Feedback from Swedish MPA on Planned Clinical Study with ELC-401 in Grade IV Glioma
Jun 08, 2026
Cision
Press Release: Elicera Therapeutics : Elicera's Nomination Committee Proposes Margareth Jorvid as New Chair of the Board
May 25, 2026
FinanzNachrichten
Elicera Therapeutics: Elicera Therapeutics AB: Elicera Therapeutics announces that the final reporting and final payment from the EIC Accelerator for the CARMA study have been approved
May 13, 2026
Marketscreener
Elicera Therapeutics: Elicera Therapeutics' CSO takes temporary leave to undergo medical treatment - Di Yu appointed Acting CSO
May 11, 2026
FinanzNachrichten
Elicera Therapeutics: Elicera Therapeutics AB: Elicera publishes information document regarding the rights issue
Apr 21, 2026
Cision
Press Release: Elicera Therapeutics : Elicera Therapeutics carries out a rights issue of approximately SEK 73 million
Mar 20, 2026
Cision
Press Release: Elicera Therapeutics : Elicera Therapeutics Announces Swedish Cancer Society's Senior Investigator Award to Chief Development Officer Di Yu